Acne 

Actinic Keratosis 

Aesthetics

Alopecia

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

COVID-19

Drug Watch

Eczema

General Dermatology 

Hidradenitis Suppurativa

Melasma

NP and PA

Pediatric Dermatology

Pigmentary Disorders 

Practice Management 

Precision Medicine and Biologics

Prurigo Nodularis

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer (Nonmelanoma)

Skin Cancer

Vitiligo

Wound Care

News

Media

Around the Practice

Between The Lines

Case-Based Peer Perspective

Clinical Case Collective

DermView

Expert Perspectives

Fellows Face Off

Frontline Forum

Medical World News

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Conferences

Conference Coverage

Conference Listing

Events

Case-Based Roundtable

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Interactive Tools

Job Board

Partner Perspectives

Polls

Editorial Advisory Board

Partners

Subscribe

Maddi Hebebrand is an associate editor of 

and joined the MJH Life Sciences team in May 2024. She attended Baldwin Wallace University, studying Media Production and Film, and is now finishing her Masters in Digital Media through Ohio University. When she's not writing, Maddi loves to read, attend concerts and spend time with her family.

Articles

Catch up on coverage from the first day of the Maui Derm NP+PA Fall 2024 conference in Nashville, Tennessee. 

Day 1 Recap: Maui Derm NP+PA Fall 2024

Hawkes highlights groundbreaking therapies for psoriasis, including new oral medications and IL-23 inhibitors.

New and Upcoming Psoriasis Therapies with Jason Hawkes, MD

Allie Karas is the vice president of content for the Health Care Specialty Group division of MJH Life Sciences. She attended Rider University and earned a degree in journalism before pursing a masters in magazine writing from New York University. Prior to making a switch to health care news in 2018, Allie spent 6 years in New York City working in political journalism. She enjoys spending time with her husband and 3 kids, cooking, working out, and her dog Bo. Follow her on Twitter at 

At Maui Derm NP+PA Fall 2024, Melodie Young, MSN, ANP-c, reviews new treatment options for pediatric patients with psoriasis and details the difference in disease manifestation between adults and children. 

Melodie Young, MSN, ANP-c: Key Psoriasis Treatment Advances for Pediatric Patients

The IL-13 inhibitor, recently FDA-approved for moderate to severe AD, reached all primary endpoints in the study focusing on patients with skin of color.

Lebrikizumab Shows Promise for Patients with Skin of Color and AD

About

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Twitter

Facebook

Linkedin

Topics

Acne

Pigmentary Disorders

Practice Management

Psoriasis

Psoriatic Arthritis

Rosacea

Case Based Peer Perspectives

Real-world, case-based insights, with experts sharing how they would approach and treat a specific scenario, including what they are looking for in a diagnosis. Hear about complex cases you could encounter, often accompanied by real patient images.

1rem

Journey Through Vitiligo Patient Cases: Strategies for Effective Treatment

Videos

Chesahna Kindred, MD, discusses the emotional impact and treatment perspectives across cultures.

Exploring the Emotional Impact and Treatment Perspectives Across Cultures

Chesahna Kindred, MD, discusses the psychological and insurance challenges associated with vitiligo. 

Vitiligo Case Discussions: Navigating Emotional, Psychological, and Insurance Challenges

Chesahna Kindred, MD, discusses strategies for facial involvement and difficult repigmentation areas in association with advanced vitiligo care. 

Advanced Vitiligo Care: Strategies for Facial Involvement and Difficult Repigmentation Areas

Chesahna Kindred, MD, discusses real-world experiences and cultural considerations associated with topical ruxolitinib for the treatment of vitiligo. 

Topical Ruxolitinib in Vitiligo: Real-World Experiences and Cultural Considerations